Your browser doesn't support javascript.
loading
Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis.
Liu, Hien D; Su, Leon; Winters, Jeffrey L; Thibodeaux, Suzanne R; Park, Yara A; Wu, YanYun; Schwartz, Joseph; Zubair, Abba C; Schneiderman, Jennifer; Gupta, Gaurav K; Ramakrishnan, Sharanya; Aqui, Nicole A.
Afiliación
  • Liu HD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, Florida, USA. Electronic address: hien.liu@moffitt.org.
  • Su L; Department of Pathology and Laboratory Medicine, Phoenix Children's Hospital, Phoenix, Arizona, USA.
  • Winters JL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Thibodeaux SR; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Park YA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Wu Y; Department of Pathology and Laboratory Medicine, University of Miami, Miami, Florida, USA.
  • Schwartz J; Department of Pathology, Molecular and Cell-Based Medicine, Mount Sinai Health System, Icahn School of Medicine, New York, New York, USA.
  • Zubair AC; Laboratory Medicine and Pathology and Center for Regenerative Medicine, Mayo Clinic, Jacksonville, Florida, USA.
  • Schneiderman J; Department of Pediatric Hematology/Oncology/Neuro-Oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Gupta GK; Division of Transfusion Medicine and Cellular Therapy, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Ramakrishnan S; Department of Clinical Hematology and Bone Marrow Transplant, Tata Medical Center, Kolkata, India.
  • Aqui NA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Cytotherapy ; 24(9): 916-922, 2022 09.
Article en En | MEDLINE | ID: mdl-35398001

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos Tipo de estudio: Guideline / Qualitative_research País/Región como asunto: America do norte Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos Tipo de estudio: Guideline / Qualitative_research País/Región como asunto: America do norte Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article